These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8311083

  • 1. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy.
    Cattran DC, Greenwood C, Ritchie S.
    Am J Kidney Dis; 1994 Feb; 23(2):247-54. PubMed ID: 8311083
    [Abstract] [Full Text] [Related]

  • 2. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
    Kanno Y, Okada H, Saruta T, Suzuki H.
    Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
    [Abstract] [Full Text] [Related]

  • 3. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
    Woo KT, Lau YK, Wong KS, Chiang GS.
    Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin converting enzyme inhibition delays the progression of chronic renal failure in hypertensive patients with immunoglobulin A nephropathy.
    Feriozzi S, Pierucci A, Roscia E, Cinotti GA, Pecci G.
    J Hypertens Suppl; 1989 Sep; 7(7):S63-4. PubMed ID: 2559173
    [Abstract] [Full Text] [Related]

  • 5. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
    Shi X, Chen X, Liu S, Zhuang Y, Zhang Y.
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603
    [Abstract] [Full Text] [Related]

  • 6. Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone.
    Hwang YC, Lee TW, Kim MJ, Yang MH, Ihm CG.
    Korean J Intern Med; 2001 Jun; 16(2):105-9. PubMed ID: 11590896
    [Abstract] [Full Text] [Related]

  • 7. [Clinical effects of trandolapril in chronic glomerulonephritis patients with renal insufficiency].
    Yoshida A, Takeda A, Fukuda M, Toda S, Morozumi K.
    Nihon Jinzo Gakkai Shi; 2000 May; 42(4):333-7. PubMed ID: 10897592
    [Abstract] [Full Text] [Related]

  • 8. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.
    Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ.
    Am J Kidney Dis; 1999 Nov; 34(5):809-17. PubMed ID: 10561135
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
    Omata K, Kanazawa M, Sato T, Abe F, Saito T, Abe K.
    Kidney Int Suppl; 1996 Jun; 55():S57-62. PubMed ID: 8743512
    [Abstract] [Full Text] [Related]

  • 10. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H.
    Am J Nephrol; 2000 Jun; 20(5):373-9. PubMed ID: 11092994
    [Abstract] [Full Text] [Related]

  • 11. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy.
    Russo D, Pisani A, Balletta MM, De Nicola L, Savino FA, Andreucci M, Minutolo R.
    Am J Kidney Dis; 1999 May; 33(5):851-6. PubMed ID: 10213639
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis.
    Woo KT, Lau YK, Chan CM, Wong KS.
    Ann Acad Med Singap; 2008 May; 37(5):372-6. PubMed ID: 18536822
    [Abstract] [Full Text] [Related]

  • 13. [Comparative study of the reno-protective effect of short- and long-acting antihypertensive agents in IgA nephropathy].
    Vas T, Kovács T, Szelestei T, Csiky B, Nagy J.
    Orv Hetil; 1999 Sep 05; 140(36):1991-5. PubMed ID: 10506823
    [Abstract] [Full Text] [Related]

  • 14. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 05; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 15. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
    Stigant CE, Cohen J, Vivera M, Zaltzman JS.
    Am J Kidney Dis; 2000 Jan 05; 35(1):58-63. PubMed ID: 10620545
    [Abstract] [Full Text] [Related]

  • 16. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013 Jan 05; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 17. [Successful treatment of combination therapy using an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker in a patient with IgA nephropathy].
    Horino T, Ito H, Tanimoto N, Yoshida T, Sasaoka A, Chijiwa T, Hosokawa T, Hashimoto K.
    Nihon Jinzo Gakkai Shi; 2003 Jan 05; 45(2):104-8. PubMed ID: 12703406
    [Abstract] [Full Text] [Related]

  • 18. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S.
    Clin Nephrol; 2005 Jul 05; 64(1):35-40. PubMed ID: 16047643
    [Abstract] [Full Text] [Related]

  • 19. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov 05; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 20. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
    Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T.
    J Am Soc Nephrol; 2007 Jun 05; 18(6):1880-8. PubMed ID: 17513327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.